Dr. Henry Ji,
Chairman, President and Chief Executive Officer

Dr Henry Ji

Henry Ji, Ph.D., co-founded and has served as a director of Sorrento since January 2006, and as its Chief Executive Officer and President since September 2012. Dr. Ji served as Sorrento’s Chief Scientific Officer from November 2008 to September 2012 and as its Interim Chief Executive Officer from April 2011 to September 2012.

 | read more »


Jerome B. Zeldis, M.D., Ph.D.,
Chief Medical Officer and President of Clinical Research, Medical Affairs and Regulatory

Jerome Zeldis, M.D., Ph.D.

Dr. Jerome (“Jerry”) Zeldis, joins Sorrento after a nearly 20-year career at Celgene during which he was instrumental in growing Celgene into one of the leading global biopharmaceutical companies. Most recently, Dr. Zeldis held the position of Chief Executive Officer of Celgene Global Health and Chief Medical Officer of Celgene.

 | read more »


George Ng, J.D.,
Executive Vice President and Chief Administrative and Legal Officer

George Ng

George Ng, J.D., is Executive Vice President and Chief Administrative Officer for Sorrento Therapeutics, Inc., where he heads the legal, human resources, compliance, quality and intellectual property functions.

 | read more »


Dean Ferrigno,
Vice President of Finance and Chief Accounting Officer

headshot of Dean

Dean Ferrigno has served as Chief Accounting Officer of Sorrento Therapeutics since May 2017 and leads the Accounting & Finance group. Mr. Ferrigno came to Sorrento through the acquisition of Scilex Pharmaceuticals as Vice President of Finance since Nov. 2016.

 | read more »


Alexis Nahama, D.V.M.,
Vice President of Corporate Development and President Ark Animal Health

headshot of Alexis

Dr Alexis Nahama is currently Vice-President, Corporate Development, and President of Ark Animal Health (a fully owned subsidiary of Sorrento).

 | read more »


Dr. Hui Li,
Vice President of Business Development and General Manager of China Operations

headshot of Hui

Dr. Hui Li is currently Vice President of Business Development and General Manager of China Operations, a subsidiary of Sorrento Therapeutics. In this role, Dr. Li is responsible for Sorrento’s partnership set up and licensing negotiations, as well as operation of Sorrento’s Chinese subsidiaries.

 | read more »


Dr. Gunnar F. Kaufmann,
Senior Vice President of Immunotherapy & Head of Research and Global Partnerships

Dr. Gunnar F. Kaufmann is currently the Senior Vice President of Immunotherapy & Head of Research and Global Partnerships at Sorrento Therapeutics.

 | read more »


Mark R. Brunswick, Ph.D.,
Vice President of Regulatory Affairs and Quality

headshot of Mark

Dr. Mark Brunswick has over 35 years of experience in Regulated Industry including over 9 years in the US FDA, Center for Biologics, Division of Monoclonal Antibodies.

 | read more »


Robert Knight, M.D.,
Vice President of Clinical Research

headshot of Mark

Dr. Robert Knight is a Hematologist/Oncologist with over 25 years of Pharmaceutical Industry experience. He has participated in the development of therapeutic agents for both hematologic malignancies and solid tumor cancers.

 | read more »


Stephen L. Klincewicz, D.O., M.P.H., J.D.
Vice President of Pharmacovigilance and Clinical Operations

headshot of Stephen

Steve has over 20 of years of experience in the pharmaceutical industry and has previously held position with Mesoblast Ltd, Bayer HealthCare Consumer Care Division, Johnson and Johnson, and Astra Zeneca.

 | read more »


Bill Farley,
Vice President of Sales and Business Development

headshot of Bill

Bill Farley, Vice President Sales and Business Development has over 30 years’ experience in the Business Development, Sales and leading efforts in drug discovery, development and partnering.

 | read more »